Clare Y Slaney

13PUBLICATIONS
53CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 29, 2025
Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft models.

Xin Du, Pei K Goh, Chenkai Ma

|Aug 25, 2025
Optimised modular anti-FLAG CAR T cells for solid tumor therapy.

Xiaomeng Zhang, Rachel Xu, Dmitry Zorin

|Dec 02, 2024
Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals.

Palak H Mehta, Gemma S Trollope, Patrick Leung

|Apr 05, 2023
T<sub>STEM</sub>-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models.

Deborah Meyran, Joe Jiang Zhu, Jeanne Butler

|Mar 23, 2023
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells.

Yuchen Bai, Carolin Gotz, Ginevra Chincarini

|Feb 25, 2023
Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges.

Evan G Pappas, Michael H Kershaw, Clare Y Slaney

Pageof 3

Frequent Collaborators

3 joint publications

Joseph A Trapani

3 joint publications

Phillip K Darcy

2 joint publications

Jack D Chan

2 joint publications

Michael H Kershaw